1. Switzerland Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
DocMorris Ltd

DocMorris Ltd

17.02
EUR
-0.22
(-1.28%)
466.13MMarket Cap
Mar 18Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
132.45
133.22
121.04
95.49
92.76
93.63
77.04
80.13
88.14
42.54
40.89
42.64
29.04
- -
Basic EPS, GAAP
-2.25
1.04
0.5
-1.39
-3.42
-3.02
-2.98
-7.36
-11.52
-7.82
3.47
-4.08
-3.47
- -
Free Cash Flow per Basic Share
-1.26
-1.26
0.53
-3.66
-4.14
-5.02
-7.05
-6.91
-9.91
-6.57
-5.01
-2.31
-2.99
- -
Dividend per Share
0.22
- -
0.28
0.18
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
10.67
11.26
10.56
11.27
22.17
26.29
23.01
27.36
23.3
14.95
18.02
14.17
8.42
7.31
Tangible Book Value per Share
3.35
3.94
2.76
4.42
11.04
10.6
-3.38
-3.74
-5.31
-9.43
-2.7
-6.44
-1.47
-2.35
Basic Weighted Avg Shares
7
7
7
9
11
13
18
18
20
22
24
24
39
49
Sales/Revenue/Turnover
911
916
834
880
983
1,207
1,356
1,477
1,727
931
969
1,017
1,124
- -
Operating Margin (%)
-0.68
0.85
0.96
-0.86
-3.94
-2.76
-4.76
-8
-11.33
-16.2
-8.52
-10.28
-8.95
- -
Depreciation Expense
8
9
7
9
17
19
32
39
51
40
43
46
45
- -
Net Income, GAAP
-15
7
3
-13
-36
-39
-52
-136
-226
-171
82
-97
-134
- -
Effective Tax Rate (%)
- -
- -
14.79
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1.7
0.78
0.41
-1.45
-3.69
-3.23
-3.86
-9.19
-13.07
-18.38
8.49
-9.56
-11.95
- -
Working Capital
63
61
54
21
154
298
215
383
325
155
113
97
160
120
LT Debt
58
58
62
9
3
116
349
520
520
493
236
308
262
261
Total Equity
73
77
73
104
294
444
406
532
485
351
431
340
409
358
Return on Invested Capital (%)
- -
- -
4.86
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
4.09
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-19.38
9.49
4.59
-14.46
-18.22
-10.57
-12.33
-28.95
-44.41
-40.95
21.06
-25.24
-35.88
- -

Capital Structure

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
4
26
4
LT Borrowings
286
243
244
LT Finance Leases
20
19
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
49
49
Market Capitalization
307
286
430

Working Capital

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
354
295
258
Cash, Cash Equivalents & STI
230
159
99
Accounts Receivable, Net
51
63
71
Inventories
43
48
48
Total Current Liabilities
109
134
137
Payables & Accruals
- -
- -
- -
ST Debt
4
26
4
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.49%
-2.89%
20.27%
Free Cash Flow
-78.88%
13.1%
109.92%
Net Income, GAAP
-37.17%
-57.19%
38.19%
Sales/Revenue/Turnover
5.17%
-1.92%
10.56%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,017
2025
- -
- -
1,124
2026
- -
- -
- -

Semi-annual Earnings Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-4.08
2025
- -
- -
-3.47
2026
- -
- -
- -

Semi-annual Dividends Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Walter Hess
Full Time Employees
1,418
Sector
Distribution services
Industry
Medical distributors
Address
Walzmühlestrasse 49 Frauenfeld TH Switzerland 8500
IPO Date
Jul 6, 2017
Website
corporate.docmorris.com
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
DocMorris AG operates as a leading European digital health company focused on online pharmacy, marketplace services, and professional health services. The company offers prescription medicines (Rx), over-the-counter (OTC) medicines, consumer health products, beauty and personal care (BPC) items, nutritional supplements, painkillers, first aid products, and private label OTC medicines through its core online pharmacy business; marketplace services providing assortment expansion via over 1,500 pharmacy and seller partners across Europe and fast delivery options including DocMorris Express same-day service; and professional health services encompassing telemedicine via TeleClinic with over 1,500 doctors and 1.6 million treatments delivered, partnerships with pharmaceutical companies for condition-specific digital health journeys on DocMorris Ratgeber, and solutions for health insurers including medication management, automated prescribing, direct billing, and pharmaceutical advice. DocMorris serves more than 10 million active customers primarily in Germany, the Netherlands, Spain, France, Portugal, and Switzerland, with brands such as DocMorris, PromoFarma by DocMorris, and TeleClinic; it generates the majority of revenue from its Germany segment including mail-order pharmacy and services for pharmacies, alongside its Europe segment marketplace operations. Founded in 1993 and headquartered in Frauenfeld, Switzerland, the company, formerly Zur Rose Group, rebranded to DocMorris AG in May 2023 following the sale of its Swiss business to Migros/Medbase to focus on core B2C operations mainly in Germany. Recent developments include a May 2025 annual general meeting approving a CHF 200 million capital increase with subscription rights to fund prescription medicines growth and potential convertible bond repayment, alongside 2024 revenue of CHF 1,085 million with 6.7% growth and accelerated Rx business expansion targeting 50% growth in early 2025; strategic partnerships such as dmr Advertising with LiveRamp and Criteo for retail media, TeleClinic with ADAC for digital healthcare access, and Klarna for payment streamlining; receipt of gematik approval for e-prescription redemption via health card, early redemption of 2025 convertible bonds, and CFO transition to Daniel Wüest; plus sustainability initiatives like reusable packaging testing and marketing campaigns emphasizing e-prescription accessibility.